There were 483 press releases posted in the last 24 hours and 427,915 in the last 365 days.

Aclaris Therapeutics to Attend Upcoming Investor Conferences

MALVERN, Pa., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that management will host investor meetings during:

  • Citi’s 2016 Global Healthcare Conference in New York, NY on Thursday, December 8, 2016
  • Guggenheim’s 2016 Annual Healthcare Conference in Boston, MA on Tuesday, December 13, 2016

About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.  Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at www.aclaristx.com.

Contact:

Aclaris Contact
Michael Tung, M.D. 
Vice President / Investor Relations
484-329-2140
mtung@aclaristx.com

Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.